Executive record
Bob Lechleider, M.D.
Public governance roles and source-backed Claims for this individual.
More
Alpha ID: alpha:person:bob-lechleider-m-d-imnmVersion: public-0:d751713988987e9331980363e24189ceAs of: 2026-10-06
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
- Executive titleExecutive title: Chief Medical OfficerIMNM executive roster source
- AI expertiseAI expertise: not identified in the cited filingIMNM executive roster source
- AI governance relevanceAI governance relevance: not identified in the cited filingIMNM executive roster source
- Executive companyExecutive at Immunome Inc.IMNM executive roster source
Biography
Previously served as Chief Medical Officer of OncoResponse and SVP Clinical Development at Seagen, with medical degree from University of Illinois.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Dates not publishedExecutive title: Chief Medical Officer · Organization not publishedIMNM executive roster source
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
IMNM executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
- Executive company: Executive at Immunome Inc. · Claim reviewed: May 3, 2026
- Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-06
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope